Healthcare provider profile · identity verified

Boris Melnikau, M.D.

Internal Medicine · NYACK, NY · NPI 1043476062

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	418	45
Amlodipine Besylate	Amlodipine Besylate	401	38
Mirtazapine	Mirtazapine	383	29
Memantine Hcl	Memantine Hcl	356	27
Pantoprazole Sodium	Pantoprazole Sodium	306	32
Metoprolol Tartrate	Metoprolol Tartrate	296	30
Tamsulosin Hcl	Tamsulosin Hcl	295	24
Levothyroxine Sodium	Levothyroxine Sodium	261	20
Divalproex Sodium	Divalproex Sodium	239	13
Metoprolol Succinate	Metoprolol Succinate	221	18
Eliquis	Apixaban	195	23
Quetiapine Fumarate	Quetiapine Fumarate	182	13
Sertraline Hcl	Sertraline Hcl	179	12
Furosemide	Furosemide	178	29
Trazodone Hcl	Trazodone Hcl	176	13
Clopidogrel	Clopidogrel Bisulfate	174	suppressed
Famotidine	Famotidine	173	19
Valsartan	Valsartan	159	15
Levetiracetam	Levetiracetam	149	15
Rosuvastatin Calcium	Rosuvastatin Calcium	144	12
Donepezil Hcl	Donepezil Hcl	143	13
Gabapentin	Gabapentin	141	23
Escitalopram Oxalate	Escitalopram Oxalate	129	11
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	117	22
Omeprazole	Omeprazole	115	suppressed
Haloperidol	Haloperidol	110	suppressed
Montelukast Sodium	Montelukast Sodium	109	11
Lisinopril	Lisinopril	102	suppressed
Metformin Hcl	Metformin Hcl	101	suppressed
Buspirone Hcl	Buspirone Hcl	95	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	89	suppressed
Duloxetine Hcl	Duloxetine Hcl	86	suppressed
Aripiprazole	Aripiprazole	85	suppressed
Baclofen	Baclofen	84	12
Latanoprost	Latanoprost	81	14
Potassium Chloride	Potassium Chloride	78	14
Benztropine Mesylate	Benztropine Mesylate	76	suppressed
Clozapine	Clozapine	71	suppressed
Lactulose	Lactulose	69	suppressed
Hydralazine Hcl	Hydralazine Hcl	68	11
Losartan Potassium	Losartan Potassium	67	suppressed
Olanzapine	Olanzapine	66	suppressed
Oxycodone Hcl	Oxycodone Hcl	66	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	64	14
Spironolactone	Spironolactone	60	suppressed
Finasteride	Finasteride	59	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	58	14
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	58	suppressed
Carvedilol	Carvedilol	58	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	57	12
Midodrine Hcl	Midodrine Hcl	57	suppressed
Januvia	Sitagliptin Phosphate	56	suppressed
Labetalol Hcl	Labetalol Hcl	56	suppressed
Prednisone	Prednisone	52	13
Allopurinol	Allopurinol	51	suppressed
Amantadine	Amantadine Hcl	51	suppressed
Entresto	Sacubitril/Valsartan	51	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	51	suppressed
Risperidone	Risperidone	48	suppressed
Sodium Chloride	0.9 % Sodium Chloride	48	15
Clonazepam	Clonazepam	43	suppressed
Jardiance	Empagliflozin	43	suppressed
Myrbetriq	Mirabegron	42	suppressed
Novolog Flexpen	Insulin Aspart	42	suppressed
Xarelto	Rivaroxaban	41	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	40	12
Amitriptyline Hcl	Amitriptyline Hcl	40	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	40	suppressed
Cefdinir	Cefdinir	39	25
Ezetimibe	Ezetimibe	37	suppressed
Methimazole	Methimazole	36	suppressed
Tradjenta	Linagliptin	36	suppressed
Methenamine Hippurate	Methenamine Hippurate	34	suppressed
Clonidine	Clonidine	33	suppressed
Clonidine Hcl	Clonidine Hcl	32	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	32	suppressed
Nifedipine Er	Nifedipine	31	suppressed
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Propranolol Hcl	Propranolol Hcl	30	suppressed
Atenolol	Atenolol	29	suppressed
Humalog Kwikpen U-100	Insulin Lispro	29	suppressed
Ondansetron Hcl	Ondansetron Hcl	29	11
Tramadol Hcl	Tramadol Hcl	29	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	28	suppressed
Metformin Hcl Er	Metformin Hcl	28	suppressed
Otezla	Apremilast	28	suppressed
Divalproex Sodium Er	Divalproex Sodium	27	suppressed
Dutasteride	Dutasteride	27	suppressed
Insulin Aspart Flexpen	Insulin Aspart	27	suppressed
Simvastatin	Simvastatin	27	suppressed
Bupropion Xl	Bupropion Hcl	26	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Haloperidol Lactate	Haloperidol Lactate	26	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	25	suppressed
Aptiom	Eslicarbazepine Acetate	25	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	25	suppressed
Fluticasone Propionate	Fluticasone Propionate	25	suppressed
Ramipril	Ramipril	25	suppressed
Olanzapine Odt	Olanzapine	24	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	24	suppressed
Topiramate	Topiramate	24	suppressed
Ertapenem	Ertapenem Sodium	23	suppressed
Haloperidol Decanoate	Haloperidol Decanoate	23	suppressed
Rivastigmine	Rivastigmine Tartrate	23	suppressed
Santyl	Collagenase Clostridium Hist.	23	suppressed
Admelog Solostar	Insulin Lispro	22	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	22	suppressed
Trulicity	Dulaglutide	22	suppressed
Vancomycin Hcl	Vancomycin Hcl	22	suppressed
Mupirocin	Mupirocin	21	suppressed
Nystop	Nystatin	21	suppressed
Raloxifene Hcl	Raloxifene Hcl	21	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	20	14
Fentanyl	Fentanyl	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	15
Bromocriptine Mesylate	Bromocriptine Mesylate	19	suppressed
Digoxin	Digoxin	17	suppressed
Icosapent Ethyl	Icosapent Ethyl	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Azithromycin	Azithromycin	16	suppressed
Novolog	Insulin Aspart	16	suppressed
Solu-Medrol	Methylprednisolone Sod Succ/Pf	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Folic Acid	Folic Acid	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Pregabalin	Pregabalin	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Valproic Acid	Valproic Acid	15	suppressed
Alendronate Sodium	Alendronate Sodium	14	suppressed
Arnuity Ellipta	Fluticasone Furoate	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Ozempic	Semaglutide	14	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Incruse Ellipta	Umeclidinium Bromide	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Ssd	Silver Sulfadiazine	13	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	12	suppressed
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Dexamethasone	Dexamethasone	11	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	11	suppressed
Meropenem	Meropenem	11	suppressed
Mometasone Furoate	Mometasone Furoate	11	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error